Video Experimental Relacionado

Updated: Jan 23, 2026

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Published on: July 16, 2017

Exploración de la interacción entre la relación estructura-actividad y el potencial anticancerígeno de derivados de

Aeyaz Ahmad Bhat¹, Iqubal Singh²

¹School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, India.

Future medicinal chemistry

|January 21, 2026

Resumen

Los investigadores exploraron compuestos de piridina para el desarrollo de fármacos contra el cáncer, centrándose en la Relación Estructura-Actividad (SAR) para identificar características estructurales clave para una mayor eficacia. Este trabajo ayuda en el diseño de nuevos agentes anticancerígenos basados en piridina.

Área de la Ciencia:

Química Medicinal
Farmacología
Química Orgánica

Sus antecedentes:

Los núcleos de piridina son componentes integrales en numerosas moléculas biológicamente activas.
El desarrollo de nuevos agentes anticancerígenos es un área crítica de la investigación farmacéutica.
La comprensión de la Relación Estructura-Actividad (SAR) es crucial para optimizar la eficacia de los fármacos.

Objetivo del estudio:

Compilar y analizar los hallazgos sobre derivados de piridina como potenciales agentes anticancerígenos.
Elucidar los principios SAR que rigen la actividad anticancerígena de los compuestos de piridina.
Desarrollar modelos cuantitativos de SAR para predecir la eficacia de análogos de piridina novedosos.

Principales métodos:

Revisión exhaustiva de la literatura de estudios que investigan derivados de piridina.
Análisis detallado de las características estructurales y su correlación con la actividad anticancerígena.
Desarrollo y validación de modelos cuantitativos de Relación Estructura-Actividad (qSAR).

Principales resultados:

Identificación de motivos estructurales esenciales en derivados de piridina responsables de efectos anticancerígenos.
Correlación entre modificaciones estructurales específicas y potencia mejorada contra diversas líneas celulares de cáncer.
Desarrollo exitoso de modelos predictivos qSAR para análogos de piridina novedosos.

Conclusiones:

Los derivados de piridina prometen significativamente como andamio para el desarrollo de nuevos fármacos contra el cáncer.
El análisis SAR proporciona una base racional para el diseño de quimioterapéuticos basados en piridina más potentes y selectivos.
La investigación adicional sobre análogos de piridina podría conducir al descubrimiento de tratamientos contra el cáncer de próxima generación.

Palabras clave:

Anticancerígeno líneas celulares de cáncer piridina relación estructura-actividad efecto de sustitución

Más Videos Relacionados

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

Videos de Conceptos Relacionados

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...